Neuroprotective Effects of RNS60 in TDP ‐43 Pathology‐Associated Amyotrophic Lateral Sclerosis
Muscle & Nerve · 2026
DOI: 10.1002/mus.70289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2026. Verfasst von Danny R Vesevick und 4 weiteren Autor:innen. Beteiligte Einrichtung: Davee Department of Neurology and Clinical Neurological Sciences, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Neuroprotective Agents, DNA-Binding Proteins. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Revalesio, Queen B Foundation, A Long Swim.
Abstract (Originalsprache)
Introduction
TDP‐43 pathology is broadly observed in the cerebral cortex of patients with amyotrophic lateral sclerosis (ALS). RNS60, an experimental treatment for acute ischemic stroke and ALS, enhanced mitochondrial biogenesis and function in other preclinical models. We investigated whether RNS60 improved mitochondrial stability and upper motor neuron (UMN) health in a TDP‐43 mouse model of ALS. Methods prpTDP‐43 A315T ‐UeGFP mice, in which UMNs express green fluorescent protein (eGFP), and WT‐UeGFP mice were treated with RNS60 or placebo intraperitoneally every other day from post‐natal day (P) 30 until P90. Astrogliosis and microgliosis in brain and spinal cord were quantified by immunocytochemistry. Mitochondrial ultrastructure was studied via electron microscopy, and mitochondrial function was assessed using flow cytometry. Neuromuscular junction (NMJ) integrity was assessed in gastrocnemius, tibialis, and diaphragm muscles.
Results
RNS60 treatment reduced defective mitochondria in UMNs (prpTDP‐43 A315T + vehicle: 53.2% ± 0.71%; prpTDP‐43 A315T + RNS60: 19.6% ± 1.4%, p = 0.0001) and spinal motor neurons (prpTDP‐43 A315T + vehicle: 70.1% ± 0.4.48%; prpTDP‐43 A315T + RNS60: 33.5% ± 4.43%, p = 0.001). It increased mitochondrial membrane polarization (prpTDP‐43 A315T ‐UeGFP + vehicle: 7184 ± 1689 mean intensity; prpTDP‐43 A315T ‐UeGFP+RNS60: 22120 ± 4818 mean intensity, p = 0.032), reduced the extent of astrogliosis and microgliosis in motor cortex and spinal cord, protected UMNs compared to placebo, and enhanced the proportion of intact NMJs in leg and diaphragm muscles (prpTDP‐43 A315T ‐UeGFP + vehicle: 29.6% ± 3.6%; prpTDP‐43 A315T ‐UeGFP + RNS60: 64.3% ± 4.4%, p = 0.0002).
Discussion
These results suggest that RNS60 treatment promotes motor neuron health in ALS by protecting mitochondrial structure and function, preserving NMJ integrity, and reducing gliosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Davee Department of Neurology and Clinical Neurological Sciences, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
- Revalesio, Tacoma, Washington, USA.
- Les Turner ALS Center, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
- Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois, USA.
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
- Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University, Chicago, Illinois, USA.
ORCID-Profile: Andreas Kalmes, Mukesh Gautam
Förderung
- Revalesio
- Queen B Foundation
- A Long Swim
Zitieren
APA
Vesevick, D. R., Ghosh, S., Kalmes, A., Ozdinler, P. H., & Gautam, M. (2026). Neuroprotective Effects of RNS60 in TDP ‐43 Pathology‐Associated Amyotrophic Lateral Sclerosis. Muscle & Nerve. https://doi.org/10.1002/mus.70289
Vancouver
Vesevick DR, Ghosh S, Kalmes A, Ozdinler PH, Gautam M. Neuroprotective Effects of RNS60 in TDP ‐43 Pathology‐Associated Amyotrophic Lateral Sclerosis. Muscle & Nerve. 2026. doi:10.1002/mus.70289
BibTeX
@article{Vesevick2026,
author = {Vesevick, Danny R and Ghosh, Supurna and Kalmes, Andreas and Ozdinler, P Hande and Gautam, Mukesh},
title = {Neuroprotective Effects of RNS60 in TDP ‐43 Pathology‐Associated Amyotrophic Lateral Sclerosis},
journal = {Muscle & Nerve},
year = {2026},
doi = {10.1002/mus.70289}
}
EUVIMED